Spherox

RSS

spheroids of human autologous matrix-associated chondrocytes

Authorised
This medicine is authorised for use in the European Union.

Overview

Spherox is a medicine used to repair defects to the cartilage in the knee in patients who are experiencing symptoms (such as pain and problems moving the knee). It is used where the affected area is no larger than 10 cm². Spherox is used in adults and in adolescents whose bones in the joints have finished growing.

Spherox contains spheroids (spherical aggregates) of chondrocytes, cells found in healthy cartilage, that have been prepared from the patient’s own tissues.

This EPAR was last updated on 20/02/2023

Authorisation details

Product details
Name
Spherox
Agency product number
EMEA/H/C/002736
Active substance
spheroids of human autologous matrix-associated chondrocytes
International non-proprietary name (INN) or common name
spheroids of human autologous matrix-associated chondrocytes
Therapeutic area (MeSH)
Cartilage Diseases
Anatomical therapeutic chemical (ATC) code
M09AX02
Publication details
Marketing-authorisation holder
CO.DON Gmbh
Revision
8
Date of issue of marketing authorisation valid throughout the European Union
10/07/2017
Contact address

Deutscher Platz 5d
Zentrum-Suedost
Saxony
04103 Leipzig
GERMANY

Product information

16/02/2023 Spherox - EMEA/H/C/002736 - IAIN/0031/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Other drugs for disorders of the musculo-skeletal system

Therapeutic indication

Repair of symptomatic articular cartilage defects of the femoral condyle and the patella of the knee (International Cartilage Repair Society [ICRS] grade III or IV) with defect sizes up to 10 cm2 in adults.

Assessment history

Related content

How useful was this page?

Add your rating
Average
1 rating
1 rating
1 rating